| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |